Tan Gao-Yi, Deng Kunhua, Liu Xinhua, Tao Hui, Chang Yingying, Chen Jia, Chen Kai, Sheng Zhi, Deng Zixin, Liu Tiangang
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences , Wuhan 430071, China.
State Key Laboratory of Bioreactor Engineering, School of Bioengineering, East China University of Science and Technology , 130 Meilong Road, Shanghai 200237, China.
ACS Synth Biol. 2017 Jun 16;6(6):995-1005. doi: 10.1021/acssynbio.6b00330. Epub 2017 Mar 13.
With the advent of the genomics era, heterologous gene expression has been used extensively as a means of accessing natural products (NPs) from environmental DNA samples. However, the heterologous production of NPs often has very low efficiency or is unable to produce targeted NPs. Moreover, due to the complicated transcriptional and metabolic regulation of NP biosynthesis in native producers, especially in the cases of genome mining, it is also difficult to rationally and systematically engineer synthetic pathways to improved NPs biosynthetic efficiency. In this study, various strategies ranging from heterologous production of a NP to subsequent application of omics-guided synthetic modules optimization for efficient biosynthesis of NPs with complex structure have been developed. Heterologous production of spinosyn in Streptomyces spp. has been demonstrated as an example of the application of these approaches. Combined with the targeted omics approach, several rate-limiting steps of spinosyn heterologous production in Streptomyces spp. have been revealed. Subsequent engineering work overcame three of selected rate-limiting steps, and the production of spinosad was increased step by step and finally reached 1460 μg/L, which is about 1000-fold higher than the original strain S. albus J1074 (C4I6-M). These results indicated that the omics platform developed in this work was a powerful tool for guiding the rational refactoring of heterologous biosynthetic pathway in Streptomyces host. Additionally, this work lays the foundation for further studies aimed at the more efficient production of spinosyn in a heterologous host. And the strategy developed in this study is expected to become readily adaptable to highly efficient heterologous production of other NPs with complex structure.
随着基因组学时代的到来,异源基因表达已被广泛用作从环境DNA样本中获取天然产物(NPs)的一种手段。然而,NPs的异源生产效率往往非常低,或者无法产生目标NPs。此外,由于天然生产者中NP生物合成的转录和代谢调控复杂,特别是在基因组挖掘的情况下,合理且系统地设计合成途径以提高NPs生物合成效率也很困难。在本研究中,已开发出从NP的异源生产到随后应用组学引导的合成模块优化以高效生物合成具有复杂结构的NPs的各种策略。以链霉菌属中多杀菌素的异源生产为例,展示了这些方法的应用。结合靶向组学方法,揭示了链霉菌属中多杀菌素异源生产的几个限速步骤。随后的工程工作克服了选定的三个限速步骤,多杀霉素的产量逐步提高,最终达到1460μg/L,比原始菌株白色链霉菌J1074(C4I6-M)高出约1000倍。这些结果表明,本研究中开发的组学平台是指导链霉菌宿主中异源生物合成途径合理重构的有力工具。此外,这项工作为进一步研究在异源宿主中更高效地生产多杀菌素奠定了基础。并且本研究中开发的策略有望很容易地适用于其他具有复杂结构的NPs的高效异源生产。